Two GDAC Members Weigh In On Prilosec 1 Without Voting
This article was originally published in The Tan Sheet
Executive Summary
An upcoming publication by FDA's Gastrointestinal Drugs Advisory Committee chairman will suggest a potential link between proton pump inhibitor therapy and the proliferation of pre-existing esophageal adenocarcinoma